The potential use of ABO blood group system for risk stratification of COVID-19.

The potential use of ABO blood group system for risk stratification of COVID-19.
复制标题

DOI:
10.1016/j.mehy.2020.110343
复制
发表时间:
2020-12
期刊:
影响因子:
4.7
通讯作者:
Fouda R
Fouda R
中科院分区:
医学4区
文献类型:
--
作者:
AbdelMassih AF;Mahrous R;Taha A;Saud A;Osman A;Kamel B;Yacoub E;Menshawey E;Ismail HA;Aita L;Dous M;Saad M;AbdelAziz M;Zaghar M;Shebl N;El-Husseiny N;Fahmy N;Hegazy N;Khalid O;Saad O;Afdal P;Menshawey R;Husseiny R;Sherien S;Salama S;Gad S;Ali S;Maalim S;Ismail S;ElHefnawi Y;Aziz Y;Fouda R

文献摘要

参考文献

被引文献

相似文献

ABO血型是一种便宜且负担得起的检测方法,可以在诊断时立即从COVID-19患者中检索。越来越多的证据表明,非O型血型对COVID-19感染的易感性和严重程度都更高。这种关系背后的原因似乎难以捉摸。关于易感性,非O型个体具有抗A抗体,可以阻止病毒进入ACE-2受体,此外,非O型个体的自身免疫、高凝状态和生态失调风险较高,导致COVID-19血管炎性后遗症的趋势增加。我们可以得出结论,在诊断水平上,ABO血型可能用于受影响的COVID-19患者的风险分层,以预测并发症风险较高的患者的恶化。在治疗水平上,来自正常O型血个体的血浆可能潜在地取代用于治疗COVID-19的恢复期血清的使用。
ABO blood groups is a cheap and affordable test that can be immediately retrieved from COVID-19 patients at the diagnosis. There is increasing evidence that non-O blood groups have both higher susceptibility and higher severity of COVID-19 infections. The reason behind such relationship seems elusive. Regarding susceptibility, Non-O individuals have Anti-A antibodies which can prevent viral entry across ACE-2 receptors, moreover, Non-O individuals are at higher risk of autoimmunity, hypercoagulable state, and dysbiosis resulting in an augmented tendency for vascular inflammatory sequelae of COVID-19. We can conclude, on the diagnostic level, that ABO blood groups can be potentially used for risk stratification of affected COVID-19 patients, to anticipate the deterioration of patients at higher risk for complications. On a therapeutic level, plasma from normal O blood group individuals might potentially replace the use of convalescent serum for the treatment of COVID-19.
DOI: 10.1016/j.obmed.2020.100281
发表时间: 2020-09-01
期刊: Obesity medicine
影响因子: --
作者:
AbdelMassih, Antoine Fakhry;Ye, Jianping;Fouda, Raghda
通讯作者: Fouda, Raghda
DOI: 10.1111/j.1537-2995.2004.03338.x
发表时间: 2004-05-01
期刊: TRANSFUSION
影响因子: 2.9
作者:
Garratty, G;Glynn, SA;McEntire, R
通讯作者: McEntire, R
DOI: 10.7717/peerj.6928
发表时间: 2019-06-12
期刊: PEERJ
影响因子: 2.7
作者:
Huang, Lin;Wang, Teng;Wan, Qi
通讯作者: Wan, Qi
DOI: 10.1016/j.numecd.2014.10.015
发表时间: 2015-04-01
影响因子: 3.9
作者:
Li, Sha;Xu, Rui-Xia;Li, Jian-Jun
通讯作者: Li, Jian-Jun
DOI: 10.11909/j.issn.1671-5411.2019.09.005
发表时间: 2019-01-01
影响因子: 2.5
作者:
Hong, Xu-Lin;Li, Ya;Zhang, Wen-Bin
通讯作者: Zhang, Wen-Bin